Aptinyx Inc. announced that Joseph Moskal, Ph.D., the company’s chief scientific officer, will be retiring from his position with the company and focusing on his academic work as a professor at Northwestern University. Dr. Moskal will continue his close association with Aptinyx in a senior advisory capacity. Dr. Moskal’s retirement from Aptinyx and transition to an advisory role with the company will commence on August 1, 2019.